Humana Inc. (NYSE:HUM) Shares Sold by Heritage Oak Wealth Advisors LLC

Heritage Oak Wealth Advisors LLC decreased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 32.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,266 shares of the insurance provider's stock after selling 2,966 shares during the quarter. Humana comprises 0.7% of Heritage Oak Wealth Advisors LLC's holdings, making the stock its 24th largest position. Heritage Oak Wealth Advisors LLC's holdings in Humana were worth $1,658,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Dodge & Cox increased its holdings in Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. lifted its stake in Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Norges Bank purchased a new position in shares of Humana in the 4th quarter valued at $416,202,000. Pzena Investment Management LLC boosted its holdings in shares of Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after acquiring an additional 1,103,132 shares during the period. Finally, Boston Partners boosted its stake in Humana by 435.8% during the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after purchasing an additional 893,637 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of analyst reports. Robert W. Baird upped their price objective on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Bank of America cut their price target on Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a report on Tuesday, June 17th. Mizuho boosted their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Barclays set a $268.00 target price on shares of Humana and gave the company an "equal weight" rating in a report on Thursday, June 12th. Finally, Oppenheimer raised their price objective on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Sixteen analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $280.76.

Humana Stock Performance

Shares of HUM traded down $5.22 during midday trading on Friday, hitting $238.58. 960,833 shares of the stock traded hands, compared to its average volume of 1,813,253. The business's 50 day moving average price is $240.79 and its two-hundred day moving average price is $258.69. The firm has a market capitalization of $28.79 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 1.84 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The firm had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. During the same period last year, the firm posted $7.23 EPS. Humana's quarterly revenue was up 8.4% compared to the same quarter last year. Equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.48%. Humana's payout ratio is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.